| ID |
PMID |
Sequence |
Chirality |
Peptide name |
Origin |
Family |
Nature |
Sub-cellular localization |
N terminal modification |
C terminal modification |
Uptake efficiency |
Uptake mechanism |
Cancer cell lines |
Patent number |
|
| 1153 | 21319732 | MDCRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (48% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1154 | 21319732 | DCRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (43% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1155 | 21319732 | DCRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (23%of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1156 | 21319732 | CRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (50% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1157 | 21319732 | CRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (33% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1158 | 21319732 | RWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (30% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1159 | 21319732 | MDCRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (31% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1160 | 21319732 | DCRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (22% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1161 | 21319732 | CRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (34% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1162 | 21319732 | RWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (10% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1183 | 21319732 | KMDXRWRWKCCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (48% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1184 | 21319732 | KMDXRWRWKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (18% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1185 | 21319732 | KMDXRWRWKXXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (4% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1186 | 21319732 | KMDXRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (70% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1187 | 21319732 | MDCRWRWKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Medium (38% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1197 | 21319732 | KMDXRPRPKCCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (6% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1198 | 21319732 | KMDXRPRPKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (5% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1199 | 21319732 | KMDXRPRPKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (6% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1200 | 21319732 | KMDCRPRPKXCKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (7% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1201 | 21319732 | KMDCRPRPKCXKK | Mod | Crot (27-39) derevative | Retal snake venom (Crotamine) | Protein derived | Cystein rich | Probably Cytosol | Labelled with K-FITC or k-FITC at N-terminus | Free | Low (9% of CyLoP1) | Probably Receptor mediated endocytic process | NIH-3T3 | US20110027300 |
|
| 1829 | 21875799 | KLULKLULKULKAULKLUGC | Mod | MAP (Aib) | Designed | Synthetic | Amphipathic | Cytoplasm and nucleus | Acetylated | Fluorescein-labeled | Higher than MAP | Unknown | A549 | Unknown |